449 related articles for article (PubMed ID: 19352175)
21. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.
Sartor RB
Gastroenterology; 2004 May; 126(6):1620-33. PubMed ID: 15168372
[TBL] [Abstract][Full Text] [Related]
22. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
Balfour Sartor R
J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
[TBL] [Abstract][Full Text] [Related]
23. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review.
Lucas López R; Grande Burgos MJ; Gálvez A; Pérez Pulido R
APMIS; 2017 Jan; 125(1):3-10. PubMed ID: 27704622
[TBL] [Abstract][Full Text] [Related]
24. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
25. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.
Carroll IM; Maharshak N
World J Gastroenterol; 2013; 19(43):7531-43. PubMed ID: 24431894
[TBL] [Abstract][Full Text] [Related]
26. Commensal-innate immune miscommunication in IBD pathogenesis.
Cario E
Dig Dis; 2012; 30(4):334-40. PubMed ID: 22796793
[TBL] [Abstract][Full Text] [Related]
27. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
[TBL] [Abstract][Full Text] [Related]
28. Adherent-invasive
Palmela C; Chevarin C; Xu Z; Torres J; Sevrin G; Hirten R; Barnich N; Ng SC; Colombel JF
Gut; 2018 Mar; 67(3):574-587. PubMed ID: 29141957
[TBL] [Abstract][Full Text] [Related]
29. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
Fritsch J; Abreu MT
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
[TBL] [Abstract][Full Text] [Related]
30. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
Henson MA; Phalak P
BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051
[TBL] [Abstract][Full Text] [Related]
31. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease.
Khan S; Imran A; Malik A; Chaudhary AA; Rub A; Jan AT; Syed JB; Rolfo C
Crit Rev Clin Lab Sci; 2019 Jan; 56(1):1-17. PubMed ID: 30373492
[TBL] [Abstract][Full Text] [Related]
32. What immunologists should know about bacterial communities of the human bowel.
Tannock GW
Semin Immunol; 2007 Apr; 19(2):94-105. PubMed ID: 17035042
[TBL] [Abstract][Full Text] [Related]
33. Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.
Desilets M; Deng X; Rao C; Ensminger AW; Krause DO; Sherman PM; Gray-Owen SD
Inflamm Bowel Dis; 2016 Jan; 22(1):1-12. PubMed ID: 26444104
[TBL] [Abstract][Full Text] [Related]
34. The intestinal microbiota in inflammatory bowel diseases.
Sartor RB
Nestle Nutr Inst Workshop Ser; 2014; 79():29-39. PubMed ID: 25227293
[TBL] [Abstract][Full Text] [Related]
35. Bacteria in the pathogenesis of inflammatory bowel disease.
Subramanian S; Campbell BJ; Rhodes JM
Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
[TBL] [Abstract][Full Text] [Related]
36. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
Mishima Y; Sartor RB
J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
[TBL] [Abstract][Full Text] [Related]
37. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
Prantera C; Scribano ML
Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
[TBL] [Abstract][Full Text] [Related]
38. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome.
Knights D; Lassen KG; Xavier RJ
Gut; 2013 Oct; 62(10):1505-10. PubMed ID: 24037875
[TBL] [Abstract][Full Text] [Related]
39. The role of mucosal immunity and host genetics in defining intestinal commensal bacteria.
Hansen J; Gulati A; Sartor RB
Curr Opin Gastroenterol; 2010 Nov; 26(6):564-71. PubMed ID: 20871399
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.
Andoh A; Fujiyama Y
World J Gastroenterol; 2006 Jul; 12(28):4452-60. PubMed ID: 16874854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
